These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14571301)

  • 1. Ezetimibe and cholesterol absorption.
    Lavoie MA
    Can J Clin Pharmacol; 2003; 10 Suppl A():7A-12A. PubMed ID: 14571301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk.
    Ros E
    Atherosclerosis; 2000 Aug; 151(2):357-79. PubMed ID: 10924713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis.
    Huff MW
    Can J Clin Pharmacol; 2003; 10 Suppl A():26A-32A. PubMed ID: 14571303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cholesterol absorption as a target for the treatment of hypercholesterolemia].
    Bitzur R; Cohen H; Harats D
    Harefuah; 2006 Nov; 145(11):831-5, 861, 860. PubMed ID: 17183957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ezetimibe--intestinal cholesterol absorbtion inhibitor].
    Pikto-Pietkiewicz W; Pasierski T
    Kardiol Pol; 2006 Dec; 64(12):1434-41. PubMed ID: 17206545
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver.
    Yamagishi S; Nakamura K; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(4):844-6. PubMed ID: 16188393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular risk factor reduction. Cholesterol absorption inhibitors: a new action principle].
    Schunack W
    Pharm Unserer Zeit; 2003; 32(6):498-502. PubMed ID: 14639831
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on patented cholesterol absorption inhibitors.
    Chhabria MT; Mahajan BM
    Expert Opin Ther Pat; 2009 Aug; 19(8):1083-107. PubMed ID: 19552506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Change in the cholesterol metabolism associated with the combined inhibition of synthesis and absorption].
    Márk L; Paragh G
    Orv Hetil; 2007 Apr; 148(14):627-32. PubMed ID: 17403635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.
    Berthold HK; Laaksonen R; Lehtimäki T; Gylling H; Krone W; Gouni-Berthold I
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):262-7. PubMed ID: 18072016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class B scavenger receptor-mediated intestinal absorption of dietary beta-carotene and cholesterol.
    van Bennekum A; Werder M; Thuahnai ST; Han CH; Duong P; Williams DL; Wettstein P; Schulthess G; Phillips MC; Hauser H
    Biochemistry; 2005 Mar; 44(11):4517-25. PubMed ID: 15766282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezetimibe for hypercholesterolemia.
    Morris S; Tiller R
    Am Fam Physician; 2003 Oct; 68(8):1595-6. PubMed ID: 14596448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New treatment option for decreasing blood cholesterol level--clinical significance of inhibition of both, cholesterol absorption and synthesis].
    Paragh G; Márk L; Czine Z
    Orv Hetil; 2004 Apr; 145(15):805-11. PubMed ID: 15188635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ezetimibe: cholesterol lowering and beyond.
    Bays HE; Neff D; Tomassini JE; Tershakovec AM
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):447-70. PubMed ID: 18402536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Improved antilipemic drug is approved. Cholesterol absorption is inhibited].
    MMW Fortschr Med; 2002 Nov; 144(46):69. PubMed ID: 12534088
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacologic elegance of inhibiting cholesterol absorption and synthesis while providing a homeostatic balance.
    Catapano AL
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():21-6. PubMed ID: 18001316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption.
    Altmann SW; Davis HR; Zhu LJ; Yao X; Hoos LM; Tetzloff G; Iyer SP; Maguire M; Golovko A; Zeng M; Wang L; Murgolo N; Graziano MP
    Science; 2004 Feb; 303(5661):1201-4. PubMed ID: 14976318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.